Ngwaahịa
-
Ọrịa Hepatitis B nke dị n'elu nje (HBsAg)
A na-eji ngwa a maka ịchọpụta ihe gbasara ọrịa hepatitis B surface antigen (HBsAg) n'ọbara mmadụ, plasma na ọbara dum.
-
Sistemụ Nchọpụta Molekụlụ Akpaka Eudemon™ AIO800
EudemonTMSistemụ Nchọpụta Molekụla AIO800 akpaka nke ejiri ihe ndọta magnetik na ọtụtụ teknụzụ PCR fluorescent nwere ike ịchọpụta nucleic acid ngwa ngwa na nke ọma na ihe nlele, ma mee nchọpụta molekụla ahụike n'ezie "Sample in, Zaa".
-
Njikọ HIV Ag/Ab
A na-eji ngwa a achọpụta ihe gbasara HIV-1 p24 antigen na HIV-1/2 antibody n'ọbara mmadụ dum, serum na plasma.
-
Ngwa Nchọpụta HIV 1/2 Ab Ngwa Ngwa Nchọpụta Ngwa Ngwa (Colloidal Gold)
A na-eji ngwa a maka nchọpụta nke nje HIV1/2 (antibody) nke na-egbochi ahụ mmadụ n'ọbara, serum na plasma.
-
Ụdị 15 nke nje virus mmadụ nwere ike ibute nnukwu nsogbu E6/E7 mRNA
Ngwa a bụ iji chọpụta ọkwa mRNA mkpụrụ ndụ ihe nketa mmadụ iri na ise (HPV) E6/E7 nwere ike ịpụta n'ihe ize ndụ dị elu na mkpụrụ ndụ ndị a na-ewepụ n'ime akpanwa nwanyị.
-
Ụdị 28 nke Nje Virus Papilloma Mmadụ Dị Oke Njọ (16/18 Types) Nucleic Acid
Asambodo: CE, Vietnam MDA, TFDA, AMMPS
Ngwa a dabara adaba maka nchọpụta njirimara in vitro nke ụdị nje papilloma mmadụ iri abụọ na asatọ (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid n'ime mmamịrị nwoke/nwanyị na mkpụrụ ndụ nwanyị a na-ewepụ akpụkpọ ahụ. Enwere ike ịpịpụta HPV 16/18, enweghị ike ịpịpụta ụdị ndị fọdụrụ kpamkpam, na-enye ụzọ enyemaka maka nchọpụta na ọgwụgwọ nke ọrịa HPV.
-
Ụdị Ngwa Nchọpụta Asịd HPV Nucleic 28 (Fluorescence PCR)
Koodu Ngwaahịa
HWTS-CC003
Nkwado Ngwaahịa
CE
A na-eji ngwa a maka nchọpụta njirimara in vitro nke ụdị papillomavirus mmadụ iri abụọ na asatọ (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acids dị na mmamịrị mmadụ, swab cervical nwanyị na ihe nlele swab ikpu nwanyị, mana enweghị ike idetuo papillomavirus mmadụ ndị a kpamkpam. Ọ nwere ike inye naanị ụzọ enyemaka maka nchọpụta na ọgwụgwọ nke ọrịa HPV.
-
Mkpụrụ ndụ ihe nketa nke mmadụ (ụdị 28)
Nkwado Ngwaahịa
CE, Serbia MoH, TFDA, AMMPS
A na-eji ngwa a maka nchọpụta qualitative na genotyping nke nucleic acid nke ụdị 28 nke human papillomavirus (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) na mmamịrị nwoke/nwanyị na mkpụrụ ndụ nwanyị a na-ewepụ akpụkpọ ahụ, na-enye ụzọ enyemaka maka nchọpụta na ọgwụgwọ nke ọrịa HPV.
-
Enterococcus na-eguzogide ọgwụ na mkpụrụ ndụ ihe nketa na-eguzogide ọgwụ ọjọọ nke Vancomycin
A na-eji ngwa a maka nchọpụta nke enterococcus na-eguzogide vancomycin (VRE) na mkpụrụ ndụ ihe nketa ya na-eguzogide ọgwụ VanA na VanB n'ime sputum mmadụ, ọbara, mmamịrị ma ọ bụ ebe obibi dị ọcha.
-
Mgbanwe Mkpụrụ Ndụ Ihe nketa nke CYP2C9 na VKORC1 nke Mmadụ
Ngwa a dabara adaba maka nchọpụta njirimara in vitro nke polymorphism nke CYP2C9*3 (rs1057910, 1075A>C) na VKORC1 (rs9923231, -1639G>A) na genomic DNA nke ihe nlele ọbara mmadụ dum.
-
Mgbanwe Mkpụrụ Ndụ Ihe nketa CYP2C19 nke Mmadụ
A na-eji ngwa a maka nchọpụta njirimara in vitro nke polymorphism nke mkpụrụ ndụ ihe nketa CYP2C19 CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*17 (rs12248560, c.806>T) na genomic DNA nke ihe nlele ọbara mmadụ dum.
-
Acid Nucleic nke Mmadụ nke a na-akpọ Antigen B27
A na-eji ngwa a maka nchọpụta nke DNA dị mma n'ụdị antigen leukocyte mmadụ nke HLA-B*2702, HLA-B*2704 na HLA-B*2705.
